Cibc World Market Inc. Intellia Therapeutics, Inc. Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 18,101 shares of NTLA stock, worth $407,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,101

Previous 20,237 10.55%

Holding current value

$407,634

Previous $557,000 27.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$20.02 - $27.22 $42,762 - $58,141	-2,136 Reduced 10.55%	18,101 $405,000
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $8,551 - $11,775	359 Added 1.81%	20,237 $557,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $103,733 - $144,850	4,479 Added 29.09%	19,878 $606,000
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $27,699 - $40,103	876 Added 6.03%	15,399 $487,000
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $234,832 - $312,589	6,791 Added 87.83%	14,523 $592,000
Q1 2023 May 12, 2023	SELL	$33.3 - $44.82 $25,474 - $34,287	-765 Reduced 9.0%	7,732 $288,000
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $15,044 - $28,398	453 Added 5.63%	8,497 $296,000
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $53,380 - $70,983	-990 Reduced 10.96%	8,044 $450,000
Q2 2022 Aug 10, 2022	BUY	$38.49 - $76.21 $165,276 - $327,245	4,294 Added 90.59%	9,034 $468,000
Q1 2022 May 12, 2022	BUY	$58.27 - $118.99 $88,686 - $181,102	1,522 Added 47.3%	4,740 $344,000
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $75,771 - $104,046	752 Added 30.49%	3,218 $380,000
Q3 2021 Nov 12, 2021	SELL	$132.37 - $176.78 $92,129 - $123,038	-696 Reduced 22.01%	2,466 $331,000
Q2 2021 Aug 12, 2021	SELL	$60.88 - $161.91 $127,726 - $339,687	-2,098 Reduced 39.89%	3,162 $512,000
Q1 2021 May 11, 2021	BUY	$46.59 - $83.68 $245,063 - $440,156	5,260 New	5,260 $422,000

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

88.8M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.71B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Intellia Therapeutics, Inc. Transaction History